Solaris Resources Inc. (CVE:SLS – Get Free Report) traded down 2.7% during trading on Wednesday . The company traded as low as C$5.95 and last traded at C$6.15. 53,313 shares were traded during mid-day trading, a decline of 60% from the average session volume of 132,199 shares. The stock had previously closed at C$6.32.
Solaris Resources Trading Down 2.7 %
The stock has a 50 day moving average price of C$6.15.
About Solaris Resources
SELLAS Life Sciences Group, Inc, a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer.
Recommended Stories
- Five stocks we like better than Solaris Resources
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Investing in Commodities: What Are They? How to Invest in Them
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- 3 Stocks to Consider Buying in October
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Solaris Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solaris Resources and related companies with MarketBeat.com's FREE daily email newsletter.
